News
Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
Videos
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesFrom All AnglesOn Demand: Webinars
Conferences
Conference Coverage Conference Listing
Events
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
More
Resources
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story

Subscribe

  • News
  • Videos
  • Conferences
  • Events
  • Resources
  • Subscribe
  • Blood Cancers
    • MPN
    • MDS
    • Myeloma
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Childhood Cancers
  • Gastrointestinal Cancers
    • Colorectal Cancer
    • Esophageal Cancer
    • Gastrointestinal stromal tumor
    • Liver Cancer
    • Pancreatic Cancer
  • Genitourinary Cancers
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
  • Gynecologic Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head & Neck Cancer
  • Leukemia
    • Acute Myeloid Leukemia
    • CLL
  • Lung Cancer
  • Lymphoma
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
    • Non-Hodgkin Lymphoma
  • Rare Cancers
    • Neuroendocrine Cancer
  • Sarcoma
  • Skin Cancer
    • Melanoma
  • Thyroid Cancer
Spotlight -
Blogs|
Breast Cancer Webinar Series|
Cancer Horizons|
Clinical Trial Corner|
Heal®|
Publications|
Videos
Advertisement
|Videos|July 30, 2020

EDUCATED PATIENT CLL Webinar: Looking at the CLL Landscape

Author(s)CURE staff

Leading experts in the CLL landscape discuss the latest treatment options for patients and answer questions from the CURE audience.

Advertisement

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Advertisement

Related Content

Advertisement
Dr. Pablo Prichard

What MRD Testing Can Mean for Patients With Breast Cancer and Survivors

ByDr. Pablo Prichard
February 1st 2026
Image of Dr. Obeid.

Risk Assessment Remains Vital for Patients Even After Cancer Diagnosis

ByDr. Elias Obeid
January 30th 2026
Dr. Suneel Kamath discusses the importance of biomarker-driven approaches in cancer care following the 2026 ASCO GI Symposium.

Expert insights into Biomarker-Driven Care and Emerging Targets in GI Cancer

ByDr. Suneel Kamath
January 29th 2026
image of woman.

Caregivers Often Overlook Their Own Health While Supporting Patients

ByDr. Tracy Proverbs-Singh
January 29th 2026
Image of Tracy.

Managing Nutrition Changes in Patients With Gastrointestinal Cancers

ByDr. Tracy Proverbs-Singh
January 28th 2026
Advertisement
Advertisement

Trending on CURE

1

Most Patients With HER2+ Breast Cancer Miss Standard Treatment, Study Shows

2

Smoldering Multiple Myeloma: An Overview for Newly Diagnosed Patients

3

What MRD Testing Can Mean for Patients With Breast Cancer and Survivors

4

Ibrance Adds 15 Months of Progression-Free Survival in HR+, HER2+ Breast Cancer

5

Key GI Cancer Advances from the 2026 ASCO Symposium

  • About Us
  • Advertise / Support
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • TargetedOnc.com
  • OncLive.com
  • OncNursingNews.com
  • Terms & Conditions
  • Privacy
  • Do Not Sell My Information
  • Washington My Health My Data
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.